PRDX4 and alkaline phosphatase measurement: The results showed that compared with the acute pancreatitis group, pancreatic edema, acinous necrosis, inflammatory infiltration and perivascular infiltration were significantly reduced in the treatment group, and the pancreatic injury score was decreased (Fig. 8C and D), suggesting that Prdx4 may be a therapeutic target for AP.